<DOC>
	<DOCNO>NCT01658995</DOCNO>
	<brief_summary>This double-blinded , randomize , prospective placebo-controlled clinical trial conduct within Mayo Clinic Mayo Clinic Health System . The goal research study gather information determine whether Doxycycline effective treatment unacceptable bleeding associate etonogestrel subdermal implant ( ESI ) , compare placebo .</brief_summary>
	<brief_title>Management Etonogestrel Subdermal Implant-related Bleeding</brief_title>
	<detailed_description>ESI long-acting reversible contraceptive . Though safety efficacy establish world wide , 1 % woman report use method . Its use limit bleed pattern change result request early removal , commonly within first 8 month use . Women age 18-51 year , choose ESI meet eligibility criterion , offer enrollment study time ESI insertion . Every effort make insert Implanon day consent unless medically contraindicate . Prospective diary complete start date ESI insertion . All participant contact study personnel 13 week enrollment query presence unacceptable bleeding . Bleeding concern objectively assess use modification Pictorial Blood Loss Assessment Chart ( PBLAC ) . Participants initiate contact bleed concern time 13 week post-ESI insertion offer treatment randomization time contact . The basis randomize treatment whether bleeding consider `` unacceptable '' participant . This inherently subjective , constitute basis removal request . Participants report unacceptable bleed 13 week post-ESI insertion , call bleeding concern anytime 13 week post-ESI insertion , randomize one two group , Doxycycline match placebo . Participants report unacceptable bleed continue complete diary may eligible randomized treatment unacceptable bleeding develops .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Premenopausal woman , age 1851 year Expressed desire complianceindependent contraception No current pregnancy anticipate desire childbearing within 3 year study enrollment Implanon insertion Agreement participate study related procedure evaluation document sign informed consent Current prior use Implanon Current longterm use Doxycycline indication Known structural uterine abnormality polyp , submucosal leiomyoma Prior permanent sterilization endometrial ablation Pregnancy desire childbearing within 3 year Contraindications intolerance etonogestrel Allergy intolerance Doxycycline Inability unwillingness complete study relate procedure evaluation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>51 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Implanon</keyword>
	<keyword>Etonogestrel subdermal implant</keyword>
	<keyword>Nexplanon</keyword>
	<keyword>Contraception</keyword>
	<keyword>Irregular Bleeding</keyword>
	<keyword>Menometrorrhagia</keyword>
</DOC>